Marcus Maurer
Maurer, Marcus 1966-2024
Maurer, Marcus, 1966-
Maurer, Marcus, 19..-...., professeur de dermatologie
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 30668153 (Personal)
Permalink: http://viaf.org/viaf/30668153
Preferred Forms
4xx's: Alternate Name Forms (7)
5xx's: Related Names (5)
- 551 _ _
‡a
Berlin
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _
‡a
Berlin, Freie Univ
- 510 2 _
‡a
Charité - Universitätsmedizin Berlin
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 510 2 _
‡a
Charité - Universitätsmedizin
- 551 _ _
‡a
Kaufbeuren
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
| Title | Sources |
|---|---|
| The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update |
|
| EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria |
|
| Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha |
|
| Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study. |
|
| Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial |
|
| Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study |
|
| Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines |
|
| Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study |
|
| Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria. |
|
| Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin |
|
| Epidemiology of urticaria: a representative cross-sectional population survey |
|
| Erfolgreiche Behandlung mit Mepolizumab bei einem Patienten mit therapieresistentem Wells-Syndrom |
|
| Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria |
|
| Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). |
|
| European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives |
|
| Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria |
|
| Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial the OPuS‐2 study |
|
| Evidence for Non-Allergic Mast Cell Activation in Pollen-Associated Inflammation |
|
| Evidence that the endothelin A receptor can enhance IgE-dependent anaphylaxis in mice. |
|
| F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema |
|
| Facharztprüfung Dermatologie und Venerologie 1000 kommentierte Prüfungsfragen |
|
| Fasciola hepatica Tegumental Coat Impairs Mast Cells' Ability To Drive Th1 Immune Responses |
|
| Food-Dependent Cold Urticaria: A New Variant of Physical Urticaria. |
|
| Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria |
|
| Galactose-α-1,3-Galactose Allergy Is Not a Hitherto Unrecognized Cause of Chronic Spontaneous Urticaria |
|
| German version of ItchyQoL: validation and initial clinical findings |
|
| H(1)-antihistamines and urticaria: how can we predict the best drug for our patient? |
|
| H1-antihistamine inhibition of histamine- and codeine-induced wheals does not predict response in chronic cold urticaria |
|
| Hair growth control by immunosuppression |
|
| Hair growth-modulation by adrenergic drugs. |
|
| Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients- Findings From The First International Burden of Illness Study (Assure-Csu). |
|
| Hereditary angioedema: an update on available therapeutic options |
|
| Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe |
|
| High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study |
|
| Histamine and Antihistamines in Atopic Dermatitis |
|
| Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, neopterin, and VEGF are not elevated in chronic spontaneous urticaria |
|
| How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19 |
|
| How not to miss autoinflammatory diseases masquerading as urticaria. |
|
| How to Approach Chronic Inducible Urticaria |
|
| Human Mast Cell Tryptase Is a Potential Treatment for Snakebite Envenoming Across Multiple Snake Species |
|
| [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins] |
|
| Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema |
|
| IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? |
|
| IgMand IgA in addition to IgG autoantibodiesagainst FcεRIα are frequent and associated with disease markers of chronic spontaneous urticarial |
|
| Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1. |
|
| Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". |
|
| Immunoglobulin E-Mediated Autoimmunity. |
|
| Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria |
|
| Immunoregulation in cutaneous allergy: prevention and control |
|
| Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP Study |
|
| Impaired mast cell-dependent natural immunity in complement C3-deficient mice |
|
| Impaired T-cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome. |
|
| In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional. |
|
| In psoriasis, levels of hope and quality of life are linked |
|
| An internet survey on self-reported food allergy in Greece: clinical aspects and lack of appropriate medical consultation |
|
| Mastzellen als Wachstumsmodulatoren am Modell des murinen Haarzyklus |
|
| Mastzellen sind entscheident an der Thrombin-induzierten kutanen Entzündungsreaktion beteiligt |
|
| Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany |
|
| A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation |
|
| A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs). |
|
| A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. |
|
| Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial |
|
| A Role for Bax in the Regulation of Apoptosis in Mouse Mast Cells |
|
| role of mast cells in the immune response against bacterial infections |
|
| Rolle von Mastzellen während bakteriellen Infektionen |
|
| A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle--dependent changes in mast cell--nerve fiber contacts in murine skin |
|
| socio‐economic burden of H1‐antihistamine‐refractory chronic spontaneous urticaria in Germany |
|
| Takhzyro® (Lanadelumab) Behandlung des hereditäten Angioödems neu definiert |
|
| Untersuchungen zur Induktion der Mastzell-Differenzierung durch den Zellkontakt zu Fibroblasten |
|
| Urticaria and Angioedema |
|
| Urtikaria: 100 Fragen - 100 Antworten ein Ratgeber für Patienten mit Nesselsucht |
|
| Warum haben wir Mastzellen? Mastzellen sind Schlüsselzellen der Auslösung natürlicher Immunantworten |
|
